在胃癌中,外科手术与辅助化疗相比,胃癌-A回顾性倾向匹配分析
Archana Elangovan1, Prasanth Penumadu2, Biswajit Dubashi3
1Department of Surgical Oncology, Jawaharlal Institute of Postgraduate Medical Education and Research, Pondicherry, 605 006, India.
概括
对于局部发达的胃癌,经过手术后的术前化疗显示出与辅助化疗的前期手术相似的生存结果. 这项研究在现实环境中比较了治疗序列.
科学领域:
- 在瘤学瘤学.
- 手术瘤学手术瘤学
- 胃肠病学 胃肠病学
背景情况:
- 对于局部晚期胃癌的最佳治疗顺序在全球缺乏共识.
- 国际研究结果相互矛盾,需要进一步调查.
- 本研究通过比较两种常见的治疗策略来解决辩论.
研究的目的:
- 为了比较本地晚期胃癌患者的生存结果.
- 为了评估术后化疗后的手术和前期手术后的辅助化疗.
- 为治疗决策提供现实世界的证据.
主要方法:
- 对前性维护数据 (2015-2020年) 的回顾性分析.
- 1:1的倾向得分与混变量控制相匹配.
- 使用日志等级测试和考克斯分析,比较无复发和整体生存率.
主要成果:
- 在两组中,平均整体存活时间 (21.9 vs. 18.7 个月) 或无复发存活时间 (15.1 vs. 13.5 个月) 没有显著差异.
- 匹配包括年龄,性别,瘤部位,T阶段和结节状况.
- 诸如白,博尔曼4型,更少的化疗周期,高的LNR和周围神经侵入等因素与更差的生存率相关.
结论:
- 术前化学疗法和前期手术后辅助化学疗法在局部发达的胃癌中产生可比的生存率.
- 现实世界的数据都不支持这两种方法在生存方面绝对优越.
- 进一步的研究可能会探索生活质量和特定子组的好处.
更多相关视频
10:31Intraoperative Gastroscopy for Tumor Localization in Laparoscopic Surgery for Gastric Adenocarcinoma
Published on: August 9, 2016
12.9K
07:13Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
Published on: April 18, 2025
201
相关概念视频
Comparing the Survival Analysis of Two or More Groups
302
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
302
Cancer Survival Analysis
458
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
458
